An effective diagnosis system and suitable treatment planning require the precise segmentation of thyroid nodules in ultrasound imaging. The advancement of imaging technologies has not resolved traditional imaging challenges, which include noise issues, limited contrast, and dependency on operator choices, thus highlighting the need for automated, reliable solutions. The researchers developed TATHA, an innovative deep learning architecture dedicated to improving thyroid ultrasound image segmentation accuracy. The model is evaluated using the digital database of thyroid ultrasound images, which includes 99 cases across three subsets containing 134 labelled images for training, validation, and testing. It incorporates data pre-treatment procedures that reduce speckle noise and enhance contrast, while edge detection provides high-quality input for segmentation. TATHA outperforms U-Net, PSPNet, and Vision Transformers across various datasets and cross-validation folds, achieving superior Dice scores, accuracy, and AUC results. The distributed thyroid segmentation framework generates reliable predictions by combining results from multiple feature extraction units. The findings confirm that these advancements make TATHA an essential tool for clinicians and researchers in thyroid imaging and clinical applications.
Segmenting liver tumors in medical imaging is pivotal for precise diagnosis, treatment, and evaluating therapy outcomes. Even with modern imaging technologies, fully automated segmentation systems have not overcome the challenge posed by the diversity in the shape, size, and texture of liver tumors. Such delays often hinder clinicians from making timely and accurate decisions. This study tries to resolve these issues with the development of UIGO. This new deep learning model merges U-Net and Inception networks, incorporating advanced feature selection and optimization strategies. The goals of UIGO include achieving high precision segmented results while maintaining optimal computational requirements for efficiency in real-world clinical use. Publicly available liver tumor segmentation datasets were used for testing the model: LiTS (Liver Tumor Segmentation Challenge), CHAOS (Combined Healthy Abdominal Organ Segmentation), and 3D-IRCADb1 (3D-IRCAD liver dataset). With various tumor shapes and sizes ranging across different imaging modalities such as CT and MRI, these datasets ensured comprehensive testing of UIGO’s performance in diverse clinical scenarios. The experimental outcomes show the effectiveness of UIGO with a segmentation accuracy of 99.93%, an AUC score of 99.89%, a Dice Coefficient of 0.997, and an IoU of 0.998. UIGO demonstrated higher performance than other contemporary liver tumor segmentation techniques, indicating the system’s ability to enhance clinician’s ability to deliver precise and prompt evaluations at a lower computational expense. This study underscores the effort towards advanced streamlined, dependable, and clinically useful devices for liver tumor segmentation in medical imaging.
1 February 2025 in Computational Biology and Chemistry